Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease (Q58877159)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 April 2007

edit

Language	Label	Description	Also known as
English	Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease	scientific article published on 26 April 2007

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

title

Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

main subject

chronic obstructive pulmonary disease

0 references

author

Leonardo M. Fabbri

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

author name string

Fernando Sanchez-Toril

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Andrew McIvor

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Peter Teichmann

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Dirk Bredenbroeker

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

Peter M A Calverley

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

language of work or name

English

0 references

publication date

26 April 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

published in

American Journal of Respiratory and Critical Care Medicine

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

volume

176

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

page(s)

154-161

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

cites work

Interpreting COPD prevalence estimates: what is the true burden of disease?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Epidemiology and costs of chronic obstructive pulmonary disease.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Roflumilast--an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Standardization of Spirometry, 1994 Update. American Thoracic Society

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Impact of preventing exacerbations on deterioration of health status in COPD.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

COPD exacerbations . 2: aetiology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1164%2FRCCM.200610-1563OC

retrieved

21 January 2018

Identifiers

DOI

10.1164/RCCM.200610-1563OC

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

PubMed publication ID

17463412

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17463412

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17463412%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 December 2019

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58877159&oldid=2219486836"